BACKGROUND: Men who have sex with men (MSM) are at elevated risk of having anal cancer. However, the prevalence and incidence among MSM of high-grade anal intraepithelial neoplasia (HGAIN), the putative precursor of anal cancer, is understudied, particularly in Asians. METHODS: A total of 123 HIV-positive and 123 HIV-negative MSM were enrolled at the Thai Red Cross AIDS Research Centre in Bangkok, Thailand, and followed for 12 months. Anal sample collection for human papillomavirus (HPV) genotyping and high-resolution anoscopy (HRA) with biopsies were performed at every visit. RESULTS: Mean age at enrollment was 28.9 years. HIV-positive MSM were more commonly infected with high-risk HPV types in the anus than HIV-negative MSM (57.5 vs. 36.6%; P = 0.001). The prevalence of HGAIN was 18.9% in HIV-positive and 11.4% in HIV-negative MSM (P = 0.1). The incidence of HGAIN at 12 months was 29% in HIV-positive and 8% in HIV-negative MSM (P = 0.001). The hazard ratios for incident HGAIN in multivariate models were 5.16 [95% confidence interval (CI) 1.89-14.08, P < 0.001] in MSM with persistent HPV 16 and/or 18 infection and 2.62 (95% CI 1.04-6.61, P = 0.042) in HIV-positive MSM. CONCLUSIONS: Approximately one-third of HIV-positive MSM developed incident HGAIN within 12 months. Given the relative increased prevalence of HIV among MSM worldwide, local HGAIN data are needed to guide practitioners, policy makers, and communities in planning for strategies to screen for and treat HGAIN in this population.
BACKGROUND:Men who have sex with men (MSM) are at elevated risk of having anal cancer. However, the prevalence and incidence among MSM of high-grade anal intraepithelial neoplasia (HGAIN), the putative precursor of anal cancer, is understudied, particularly in Asians. METHODS: A total of 123 HIV-positive and 123 HIV-negative MSM were enrolled at the Thai Red Cross AIDS Research Centre in Bangkok, Thailand, and followed for 12 months. Anal sample collection for human papillomavirus (HPV) genotyping and high-resolution anoscopy (HRA) with biopsies were performed at every visit. RESULTS: Mean age at enrollment was 28.9 years. HIV-positive MSM were more commonly infected with high-risk HPV types in the anus than HIV-negative MSM (57.5 vs. 36.6%; P = 0.001). The prevalence of HGAIN was 18.9% in HIV-positive and 11.4% in HIV-negative MSM (P = 0.1). The incidence of HGAIN at 12 months was 29% in HIV-positive and 8% in HIV-negative MSM (P = 0.001). The hazard ratios for incident HGAIN in multivariate models were 5.16 [95% confidence interval (CI) 1.89-14.08, P < 0.001] in MSM with persistent HPV 16 and/or 18 infection and 2.62 (95% CI 1.04-6.61, P = 0.042) in HIV-positive MSM. CONCLUSIONS: Approximately one-third of HIV-positive MSM developed incident HGAIN within 12 months. Given the relative increased prevalence of HIV among MSM worldwide, local HGAIN data are needed to guide practitioners, policy makers, and communities in planning for strategies to screen for and treat HGAIN in this population.
Authors: Paul Fox; Justin Stebbing; Simon Portsmouth; Alan Winston; Nick Frances; Mark Nelson; Brian Gazzard; Mark Bower Journal: AIDS Date: 2003-01-24 Impact factor: 4.177
Authors: J M Palefsky; E A Holly; M L Ralston; S P Arthur; N Jay; J M Berry; M M DaCosta; R Botts; T M Darragh Journal: J Acquir Immune Defic Syndr Hum Retrovirol Date: 1998-04-01
Authors: J M Palefsky; E A Holly; C J Hogeboom; M L Ralston; M M DaCosta; R Botts; J M Berry; N Jay; T M Darragh Journal: J Acquir Immune Defic Syndr Hum Retrovirol Date: 1998-04-01
Authors: N B Kiviat; C W Critchlow; K K Holmes; J Kuypers; J Sayer; C Dunphy; C Surawicz; P Kirby; R Wood; J R Daling Journal: AIDS Date: 1993-01 Impact factor: 4.177
Authors: C W Critchlow; C M Surawicz; K K Holmes; J Kuypers; J R Daling; S E Hawes; G M Goldbaum; J Sayer; C Hurt; C Dunphy Journal: AIDS Date: 1995-11 Impact factor: 4.177
Authors: Ashish A Deshmukh; Elizabeth Y Chiao; Scott B Cantor; Elizabeth A Stier; Stephen E Goldstone; Alan G Nyitray; Timothy Wilkin; Xiaojie Wang; Jagpreet Chhatwal Journal: Cancer Date: 2017-09-26 Impact factor: 6.860
Authors: Lois J Conley; Timothy J Bush; Teresa M Darragh; Joel M Palefsky; Elizabeth R Unger; Pragna Patel; Martin Steinau; E Milu Kojic; Harold Martin; E Turner Overton; Susan Cu-Uvin; John Hammer; Keith Henry; Kathleen Wood; John T Brooks Journal: J Infect Dis Date: 2015-08-12 Impact factor: 5.226
Authors: Katharine J Looker; Minttu M Rönn; Patrick M Brock; Marc Brisson; Melanie Drolet; Philippe Mayaud; Marie-Claude Boily Journal: J Int AIDS Soc Date: 2018-06 Impact factor: 5.396
Authors: Rebecca G Nowak; Lisa M Schumaker; Nicholas P Ambulos; Nicaise Ndembi; Wuese Dauda; Chinedu H Nnaji; Andrew Mitchell; Trevor J Mathias; Paul Jibrin; Teresa M Darragh; Oluwole Olaomi; Trevor A Crowell; Stefan D Baral; Manhattan E Charurat; Søren M Bentzen; Joel M Palefsky; Kevin J Cullen Journal: Papillomavirus Res Date: 2020-05-31
Authors: Rebecca G Nowak; Nicaise Ndembi; Wuese Dauda; Paul Jibrin; Søren M Bentzen; Chinedu H Nnaji; Oluwole Olaomi; Teresa M Darragh; Jonathan Madukwe; Trevor A Crowell; Stefan D Baral; William A Blattner; Manhattan E Charurat; Joel M Palefsky; Kevin J Cullen Journal: J Glob Oncol Date: 2019-07
Authors: Fernando Dias Gonçalves Lima; Janine D Viset; Mariska M G Leeflang; Jacqueline Limpens; Jan M Prins; Henry J C de Vries Journal: Open Forum Infect Dis Date: 2019-04-16 Impact factor: 3.835